Latest News & Features
Big Pharma
The UK’s Medicines and Healthcare Products Regulatory Agency is seeking industry views on a no-deal Brexit scenario. 4 October 2018
Americas
Boston Pharmaceuticals yesterday signed deals with GSK and Novartis, licensing eight drug candidates in total. 4 October 2018
Americas
Patenting antibodies across different jurisdictions can be a difficult task, as Kathy Coulter, senior IP counsel at Bristol-Myers Squibb, tells LSIPR. 4 October 2018
Americas
Costa Rica has released new rules for the clinical investigation of adult stem cells, as María del Pilar López and Esteban Monge of Zürcher Lawyers report. 4 October 2018
Big Pharma
DLA Piper has appointed Marco de Morpurgo, from Allen & Overy, as a partner in the firm’s life sciences team in Rome, Italy. 3 October 2018
Big Pharma
Joseph Lenthall has joined Haseltine Lake as a partner, after spending more than a decade at Mewburn Ellis. 3 October 2018
Biotechnology
UK governmental agency Public Health England has entered into a research and development partnership with UK-based pharmaceutical company Enesi Pharma. 3 October 2018
Americas
Scott Gottlieb, commissioner of the Food and Drug Administration,, yesterday announced another set of guidelines aimed at facilitating the entry of generic drugs to the market and preventing “gaming” of the approval system. 3 October 2018
Asia
A recent case in India reveals the various ways in which pharmaceutical patents can be challenged, as Neeti Wilson, Arpita Kulshreshtha and Gitika Suri of Anand and Anand report. 2 October 2018
Americas
Dykema has strengthened its Minneapolis, Minnesota office with the addition of two lawyers from Moore & Hansen as senior counsel. 2 October 2018